Free Trial

ACADIA Pharmaceuticals (ACAD) Insider Trading & Ownership

ACADIA Pharmaceuticals logo
$21.78 -0.02 (-0.07%)
As of 02:48 PM Eastern
This is a fair market value price provided by Massive. Learn more.

ACADIA Pharmaceuticals (NASDAQ:ACAD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
26.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$2.49M
Get ACAD Insider Trade Alerts

Want to know when executives and insiders are buying or selling ACADIA Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ACAD Insider Buying and Selling by Quarter

ACADIA Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/4/2026Sell1,332$21.79$29,024.28  
5/4/2026Sell3,506$21.79$76,395.74  
4/7/2026Sell1,030$22.20$22,866.00  
4/7/2026Sell2,709$22.20$60,139.80  
2/9/2026Sell6,950$23.38$162,491.00  
11/18/2025Sell4,084$23.69$96,749.96  
11/18/2025Sell10,262$23.69$243,106.78  
11/10/2025
James M Daly
Director
Sell30,000$22.37$671,100.00  
9/15/2025Sell3,498$23.65$82,727.70  
9/2/2025Sell1,600$25.98$41,568.00  
8/18/2025Sell22,000$25.18$553,960.00  
6/4/2025
Laura Brege
Laura Brege
Director
Sell14,446$21.78$314,633.88  
5/16/2025Sell4,000$22.50$90,000.00  
5/16/2025Sell2,000$25.00$50,000.00  
(Data available from 1/1/2013 forward)

ACAD Insider Trading Activity - Frequently Asked Questions

The list of insiders at ACADIA Pharmaceuticals includes Austin D Kim, Brendan Teehan, Bros. Advisors Lp Baker, Elizabeth A Garofalo, James Kihara, James M Daly, Jennifer J Rhodes, Laura Brege, Mark C Schneyer, and Stephen Davis. Learn more on insiders at ACAD.

26.20% of ACADIA Pharmaceuticals stock is owned by insiders. Learn more on ACAD's insider holdings.

The following insiders have sold ACAD shares in the last 24 months: Brendan Teehan ($319,310.01), Elizabeth A Garofalo ($131,241.37), James Kihara ($369,867.28), James M Daly ($671,100.00), Jennifer J Rhodes ($162,491.00), Laura Brege ($314,633.88), Mark C Schneyer ($1,562,622.29), and Stephen Davis ($485,094.16).

Insiders have sold a total of 203,061 ACADIA Pharmaceuticals shares in the last 24 months for a total of $4,016,359.99 sold.



This page (NASDAQ:ACAD) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners